1700 percent on items charged by Fortis Memorial Research Institute, says NPPA Ruby Khatun Khatun16 Dec 2017 4:47 PM ISTGurugram: Fortis hospital at Gurugram charged as high as 1700 percent cent margin on consumables and medicines used for the treatment of a dengue...
Launch new drugs without prior price approval: NPPA issues guidelines Ruby Khatun Khatun2 Dec 2017 12:25 PM ISTThrough a recent notification the National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
Cancer, cardiac among 51 essential drugs under NPPA price cap, check out details Ruby Khatun Khatun24 Nov 2017 4:15 PM ISTNew Delhi: National drug pricing regulator NPPA on Friday said it has capped prices of 51 essential formulations, including those used for the...
NPPA invites representation and suggestion on Coronary Stents Ruby Khatun Khatun14 Nov 2017 4:29 PM ISTThrough a recent notification Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and National Pharmaceutical...
Now non-essential drugs fall under price control Ruby Khatun Khatun23 Oct 2017 5:45 PM ISTNew Delhi: The government's push for a change in the method of price calculation methodology for new drugs can lead to non-essential drugs coming...
NPPA slashes price of 39 drugs: check out details Ruby Khatun Khatun21 Sept 2017 10:34 AM ISTNew Delhi: Drug price regulator NPPA on Wednesday said it has fixed the ceiling price for 39 more drug formulations, including those used for the...
Margin on revision knee surgery implants as high as 277 percent: NPPA Ruby Khatun Khatun10 Aug 2017 11:30 AM ISTNew Delhi: Drug price regulator NPPA said it has found average trade margins on various knee implants used in revision surgery to be as high as 277...
Average trade margin on knee implants as high as 313 percent: NPPA Ruby Khatun Khatun5 Aug 2017 12:30 PM ISTNew Delhi: Drug price regulator NPPA said it has found average trade margin on orthopaedic knee implants to be as high as 313 per cent and has invited...
Cannot exceed 8 percent trade margin on Stents: NPPA Ruby Khatun Khatun4 Aug 2017 6:00 PM ISTNew Delhi: NPPA has taken a step ahead to prevent distributors from grabbing higher profits and manipulating trade margins on coronary stents than the...
4 more medical devices to be added to price control list, document shows Ruby Khatun Khatun7 Jun 2017 1:36 PM ISTNew Delhi/Mumbai: India's drug-pricing regulator has asked the health ministry to add four more medical devices to a list of products eligible for...
Govt rejects Abbott, Medtronic applications to withdraw stents Ruby Khatun Khatun27 April 2017 3:29 PM ISTNew Delhi: The government on Wednesday rejected applications by multinational firms Abbott Healthcare Pvt Ltd and India Medtronic Pvt Ltd to withdraw...
Government Prohibits Stent companies to withdraw stents for Next Six Months Ruby Khatun Khatun25 April 2017 3:12 PM ISTNew Delhi: In a bid to prevent Multinational Stent makers from removing their next generation stents from the Indian Market, the central government...
